Dr. Raymond Martin Harrell, M.D. Pain Medicine - Interventional Pain Medicine Medicare: Medicare Enrolled Practice Location: 14605 Potomac Branch Dr, Suite 100, Woodbridge, VA 22191 Phone: 703-738-4371 Fax: 703-642-1876 |
Samad Oraee, MD Pain Medicine - Pain Medicine Medicare: Medicare Enrolled Practice Location: 2050 Old Bridge Rd, Ste 200, Woodbridge, VA 22192 Phone: 703-491-5367 Fax: 703-492-7537 |
News Archive
BioSight, Ltd, an Israeli pharmaceutical development company focused on the development of innovative chemotherapy pro-drugs with reduced toxicity, announced today the closing of an investment of $13M led by the Mori Arkin's pharmaceutical investment firm, Arkin Holdings, and the US based venture firm Primera Capital. Proceeds of the financing will be used to fund a multi-center phase IIb clinical trial with the company's lead product, Astarabineā¢, for the treatment of AML.
Preclinical data was published today on research performed by Cytori Therapeutics (NASDAQ:CYTX) showing adipose (fat)-derived stem and regenerative cells (ADRCs), either fresh or banked, demonstrated statistically significant improvements in animal survival and kidney function in an acute kidney injury animal model.
Researchers from the University of Wisconsin School of Medicine and Public Health and Carbone Cancer Center have better defined a pro-growth signaling pathway common to many cancers that, when blocked, kills cancer cells but leaves healthy cells comparatively unharmed.
Scientists at The Scripps Research Institute (TSRI) have discovered the first selective inhibitors of an important set of enzymes. The new inhibitors, and chemical probes based on them, now can be used to study the functions of enzymes known as diacylglycerol lipases (DAGL), their products, and the pathways they regulate.
Alzheimer Disease (AD) is characterized by hallmark lesions called amyloid plaques in the brain.
› Verified 4 days ago